Christine Arezzi
Psychiatric/Mental Health · East Stroudsburg, PANPI 1942917075
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 215 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,028, 2.8 times the $726 reported in 2023. Among psychiatric/mental health clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 215 payments — averaging $19.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$662
- Teva Pharmaceuticals USA, Inc.$646
- AbbVie$602
- Johnson & Johnson$514
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$442
- Neurocrine Biosciences, Inc.$350
- plus $981 from 8 others
What the payments were for
- Food & beverage$4,08697%
- Education$1113%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 31 | $662 |
| Teva Pharmaceuticals USA, Inc. | 36 | $646 |
| AbbVie | 43 | $602 |
| Johnson & Johnson | 25 | $514 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $442 |
| Neurocrine Biosciences, Inc. | 13 | $350 |
| Otsuka America Pharmaceutical, Inc. | 10 | $292 |
| Bausch Health US, LLC | 15 | $280 |
| Lundbeck LLC | 12 | $210 |
| Vanda Pharmaceuticals Inc. | 4 | $70 |
| Braeburn Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$125
- CAPLYTA$125
- Austedo XR$108
How this compares
$4,197 in reported general payments places this provider in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.
See all psychiatric/mental health providers in Pennsylvania →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 13 | $199 |
| Gabapentin | 12 | $92 |
| Lamotrigine | 20 | $64 |
| Quetiapine Fumarate | 23 | $64 |
| Alprazolam | 20 | $45 |
| Citalopram HbrCitalopram Hydrobromide | 17 | $33 |
| Clonazepam | 20 | $19 |
| Trazodone Hcl | 12 | $15 |
| Mirtazapine | 18 | $7 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in East Stroudsburg
- Kimberly GarciaAllentown$573K
- Cortney SmithWashington$227K
- Britney KeplerPittsburgh$158K
- Kirstyn KamegBethel Park$136K
- Anna DipietroDowningtown$131K
- Deena MasciocchiLanghorne$71K
- Joseph GagnonChesterbrook$64K
- Michelle CohenWashington$62K
- Sharon KatzJenkintown$51K
- Jennifer BowmanCanonsburg$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.